Fragile X syndrome is caused by the transcriptional silencing of the FMR1 gene due to a trinucleotide repeat expansion. The encoded protein, Fmrp, has been found to be a nucleocytoplasmic RNA-binding protein containing both KH domains and RGG boxes that associates with polyribosomes as a ribonucleoprotein particle. RNA binding has previously been demonstrated with in vitro-translated Fmrp; however, it remained uncertain whether the selective RNA binding observed was an intrinsic property of Fmrp or required an associated protein(s). Here, baculovirus-expressed and affinity-purified FLAG-tagged murine Fmrp was shown to bind directly to both ribonucleotide homopolymers and human brain mRNA. FLAG-Fmrp exhibited selectivity for binding poly(G) > poly(U) > > poly(C) or poly(A). Moreover, purified FLAG-Fmrp bound to only a subset of brain mRNA, including the 3 untranslated regions of myelin basic protein message and its own message. Recombinant isoform 4, lacking the RGG boxes but maintaining both KH domains, was also purified and was found to only weakly interact with RNA. FLAG-purified I304N Fmrp, harboring the mutation of severe fragile X syndrome, demonstrated RNA binding, in contrast to previous suggestions. These data demonstrate the intrinsic property of Fmrp to selectively bind RNA and show FLAG-Fmrp as a suitable reagent for structural characterization and identification of cognate RNA ligands.
Fragile X syndrome, a common mental retardation syndrome, results from an unstable CGG repeat expansion in the 5Ј-untranslated region of the FMR1 gene, leading to transcriptional silencing and the absence of Fmrp protein (1) (2) (3) (4) . Characterization of in vitro-translated Fmrp has shown it to be an RNA-associated protein with selectivity for homopolymer RNA and some human brain transcripts (5, 6) . Fmrp contains nuclear localization and export sequences (7) , as well as RGG box and KH domain motifs found in many RNA-binding proteins. The RGG box has been found in hnRNP 1 U, hnRNP A1, nucleolin, and fibrillarin and has been shown to autonomously bind homopolymeric RNA (8) . However, the amino acid context surrounding the RGG box may influence the specificity and avidity of the RNA-nucleic acid interaction (8, 9) . The KH domain is highly conserved in hnRNP K, yeast MER-1 splicing regulator, Sam68, and chicken vigillin, among other RNA-binding proteins (10) .
Fmrp expression is widespread but not ubiquitous. The majority of Fmrp is associated with polyribosomes and has been found to form an mRNP, which can be stripped from ribosomes by EDTA or RNase treatment (11) (12) (13) (14) . A prevailing model suggests that Fmrp directly binds specific mRNAs in the nucleus as part of a hnRNP particle and then mediates its transport to the cytoplasm and delivery of the mRNP to the ribosome (4, 7) .
Homopolymer binding assays performed with in vitro-translated Fmrp and carboxyl-terminal truncated Fmrp proteins suggested a role for both the KH domain and RGG box in RNA binding (15) . However, whether the observed RNA binding by Fmrp is mediated directly by the KH domain or through a KH-associated protein present in the translation mixture is unknown (5, 6, 12, 15) . Prior to this work, all RNA binding studies with Fmrp were performed in cell lysates. Because these in vitro systems contain concentrated quantities of ribosomes and other translation factors and because Fmrp has been shown to associate with mRNP particles and polyribosomes, direct binding of the Fmrp and RNA could not be verified. Because Fmrp associates with large protein complexes, we could not disregard the possibility that another protein in the translation mix was actually binding the RNA and that Fmrp was associating tightly yet peripherally with an RNA-binding protein in the RNP complex (5, 6, (11) (12) (13) (14) . Furthermore, if the Fmrp was truly making direct contact with the RNA, the specificity of the interaction might be modulated by other proteins bound to Fmrp. Similar situations exist for other RNA-binding proteins, such as the mammalian erythropoietin RNA-binding protein ERBP (16) and the Drosophila SR splicing proteins (17) .
We report here that the RNA binding activity and specificity of Fmrp is an intrinsic property of the protein. The purified FLAG-Fmrp binds in a salt-resistant manner to ribonucleic homopolymers with a high affinity for poly(G) and poly(U) but with weak affinity for poly(C) and poly(A). Purified Fmrp also binds specifically to the 3Ј-untranslated region of its own message and a subset of human brain transcripts. In addition, an isoform 4 of Fmrp, lacking RGG boxes, was shown to only weakly bind RNA, whereas the I304N mutation of the second KH domain was found to retain RNA binding ability. These studies show that purified recombinant Fmrp is suitable for further biochemical and structural studies and will be a useful reagent to identify cognate mRNAs.
EXPERIMENTAL PROCEDURES
Materials-Baculovirus transfer vector pVL1393 and Sf9 cells were obtained from Invitrogen Corp. BaculoGold wild type baculovirus was purchased from Pharmingen, and Grace's medium, pluronic F-68, and antibiotic/antimycotic were purchased from Life Technologies, Inc. M2 matrix, FLAG peptide, and anti-M2 monoclonal antibody were from Kodak Scientific Imaging Systems. Secondary antibodies and ECL reagents were from Amersham Pharmacia Biotech. CNBr-activated Sepharose 4B (Amersham Pharmacia Biotech) was conjugated with polyadenylic, polyguanylic, polycytidylic, or polyuridylic acid (Sigma). Bacterial vector pQE31 and Ni-NTA resin were obtained from Qiagen. Anti-Fmrp primary antibody was a generous gift from Jean-Louis Mandel.
Fmrp Constructs-The baculoviral constructs used in wild type Fmrp production were constructed by inserting the sequence GACTACAAG-GACGACGATGACAAG encoding the FLAG epitope into full-length fmr1 cDNA between the second and third amino acids. The fmr1 Mc2.17 cDNA (18) includes 123 bases upstream of the translational start codon, all 17 exons and 2288 bases of 3Ј untranslated region, including a terminal poly(A) 17 tail. Briefly, polymerase chain reaction was performed using an upstream primer (5ЈACCTCCCGGAGGATGGAGGAC-TACAAGGACGACGATGACAAGGAGC TGGTGGTGGAAGTGC-3Ј) containing at its 5Ј-terminus an EcoN1 restriction site (underlined), a methionine and glutamate codon followed by sequence encoding the FLAG epitope, and a downstream primer (5Ј-ATGAAATCTTGAG-GCAAGCTGCC-3Ј). The fragment was digested with EcoN1 and BstB1. The purified oligo was then cloned into Mc2.17 in pBS KSϩ previously restricted with EcoN1 and BstB1, deleting the endogenous sequence between the 5Ј EcoN1 site and the initiating ATG of fmr1. The cloning junctions were sequenced to verify the correct protein reading frame. For the I304N point mutant Fmrp construct, a SacII/SnaBI fragment carrying the FLAG epitope was removed from the wild type cDNA and ligated into the Mc2.17 point mutant cDNA that was previously restricted with SacII and SnaBI and that carried the A to T missense at nucleotide 1034 (19) . For the wild type and I304N constructs, a 3.9-kb EcoRI fragment containing the full, tagged cDNA without the 3Ј-terminal 256 bases of the 3Ј-UTR was cloned into the nonfusion baculovirus pVL1393 vector downstream of the AcMNPV enhancer-promoter. These constructs were co-transformed into Sf9 cells with BaculoGold AcM-NPV DNA using a cationic liposome method as recommended (Invitrogen). Sf9 cells were cultured in 1ϫ Grace's medium with 10% FBS, 0.1% pluronic F-68, and 1 ϫ antibiotic/antimycotic (Life Technologies, Inc.). Occlusion body-negative recombinant plaques on an Sf9 cell lawn were visually identified, isolated, and purified by screening crude cell lysates for recombinant protein production via Western blotting using anti-FLAG M2 and/or anti-Fmrp primary antibody. Viral DNA was extracted from high titer stocks and sequenced to confirm the amino acid codon at position 304.
For isoform 4 Fmrp production, the coding region of Mc2.14 (18) was modified by polymerase chain reaction to add SacI and SalI sites to the ends of the coding fragment. The fragment was subsequently ligated in frame to the SacI/SalI digested vector pQE31 (Qiagen). This construct places the His 6 tag 5Ј to the polylinker. The pQE expression construct was then transformed into the M15[pREP4] E. coli host strain (Qiagen), which carries the pPREP4 repressor plasmid. Transformants were selected on plates containing both ampicillin and kanamycin and were screened for the insert.
Recombinant FLAG-Fmrp-In Sf9 cells, virus was amplified to high titer by serial infections with plaque-purified, protein-producing virus as recommended (Invitrogen). Large scale purification of recombinant protein was performed as follows: 4 ϫ 10 8 cells were infected with high titer virus for 72 h at a multiplicity of infection ϭ 5 in spinning culture. Cells were harvested and resuspended in PBS, pH 7.2-7.4, containing 1 M NaCl and protease inhibitors: 1 g/ml pepstatin, 2 g/ml leupeptin and aprotinin, 10 mM N-ethylameleimide, 2 mM iodoacetamide and diisopropyl fluorophosphate, and 100 g/ml phenylmethylsulfonyl fluoride. Cells were disrupted by nitrogen cavitation for 10 min at 450 psi and subjected to centrifugation at 14,500 ϫ g for 20 min, followed by shearing the supernatant through an 18-gauge needle before centrifugation at 60,000 ϫ g for 1 h. Soluble protein was loaded onto an anti-FLAG M2 affinity column, washed with 1 ϫ PBS, 1 M NaCl, protease inhibitors, and eluted with 150 g/ml FLAG peptide. Fractions were analyzed via Coomassie Blue-stained SDS-PAGE gel, Western blotting, and Bradford protein concentration assay (Bio-Rad). Fractions containing FLAG-Fmrp were dialyzed against 1ϫ PBS, 0.75 M NaCl, 10% glycerol for 2 h; against 1ϫ PBS, 0.5 M NaCl, 10% glycerol for 2 h; and against 1ϫ PBS, 0.3 M NaCl, 10% glycerol overnight. Buffer to sample ratio was 1000:1 for each dialysis.
Recombinant His 6 Isoform 4 Fmrp-Briefly, bacteria containing the His 6 isoform 4 construct were grown at 37°C in Luria broth containing 50 g/ml carbenicillin and 25 g/ml kanamycin until the A 600 reached 0.8. We used carbenicillin, a less labile, semisynthetic form of ampicillin, for selection to ensure plasmid maintenance (QIAexpressionist, Qiagen). Recombinant protein production was then induced by the addition of isopropyl-1-thio-␤-D-galactopyranoside to a final concentration of 2 mM for 5 h, and the cells were harvested at 4000 ϫ g for 10 min. For purification, the cells were lysed for 1 h in Buffer A (6 M GuHCl, 0.1 M sodium phosphate, 0.01 M Tris-HCl, pH 8.0), followed by centrifugation at 10,000 ϫ g for 15 min at 4°C. The supernatant was subjected to a Ni-NTA column that was previously equilibrated with Buffer A. The column was then washed with 10 column volumes of Buffer B (8 M Purified His 6 isoform 4 Fmrp was refolded using cetyltrimethylammonium bromide and ␤-cyclodextrin while simultaneously removing the urea as described by Rozema and Gellman (20) . Protein was first slowly dialyzed from 8 M urea down to 3 M urea and then, at a concentration of 1.6 g/ul, was refolded by the addition of 50 mM CTAB to a final concentration of 2.28 mM. Dialysis was then performed against 23 mM Tris, 2.28 mM CTAB for 2 h at 4°C. Next, 2.5 ml of 16 mM ␤-cyclodextrin was added, and the resulting solution was allowed to stand overnight at 4°C. The protein was then concentrated with a M r 10,000 cutoff filter, simultaneously changing the buffer to 1ϫ PBS pH 7.4 (Ultrafree-15 Centrifugal Filter Device Biomax-10K NMWL membrane from Millipore, catalog no. UFV2BGC10).
Homopolymer Assays-Assays were performed according to previously established procedures (15, 21) . Briefly, homopolymer RNA was conjugated to CNBr-activated beads previously washed with 1 mM HCl and then conjugated with RNA either in carbonate buffer, pH 8.0, for primary amine linkage (Amersham Pharmacia Biotech; as recommended), MES buffer, pH 6.0, for aromatic amine linkage (22) , or potassium phosphate buffer, pH 8.5, for 5Ј phosphate linkage (23), 8 -72 h at 4°C. Beads were washed with three volumes of conjugation buffer and then twice with 100 mM Tris-HCl, pH 8.0, and blocked for at least 4 h in 100 mM Tris-HCl, pH 8.0. After blocking, the beads were washed in alternating high/low pH buffers (Amersham Pharmacia Biotech; as recommended), and conjugation efficiency was determined via alkaline hydrolysis of an aliquot overnight at room temperature. The amount of nucleic acids released was determined by measuring absorbance at 258 nm. Samples of identically prepared, mock conjugated naked beads were alkaline hydrolyzed and analyzed to exclude background absorbance. The absorbance values and extinction coefficients were used to equalize input of immobilized homopolymer RNA for each binding reaction. Experiments shown were performed with beads prepared in the carbonate buffers. Indicated amounts of FLAG-Fmrp and approximately 5 g of homopolymer RNA beads were at 30°C in 0.5 ml of binding buffer (100 mM NaCl, 10 mM Tris-HCl, pH 7.5, 2.5 mM MgCl 2 , 2.5% Triton X-100) or the buffer indicated. After incubation, the beads were washed 5 times for 10 min each at 4°C in 0.5 ml of binding buffer. The second wash contained 1 mg/ml heparin. Beads were pelleted at 12,000 rpm in a microcentrifuge, resuspended in SDS sample buffer, boiled for 20 min, and pelleted. Supernatants were transferred to fresh tubes and pelleted, and 50% of the volume was loaded on a 12% SDS-PAGE minigel for electrophoresis (Bio-Rad). This procedure was used to equalize the amount loaded for each reaction and to avoid loading agarose matrix onto the gel. Fmrp eluted from the beads was detected by Western blotting using enhanced chemiluminesence (Amersham Pharmacia Biotech).
Ultraviolet Cross-linking Assays-Full-length (4.2 kb) fmr1 message containing all 17 exons was transcribed and 32 P-labeled in vitro with T3 polymerase (Stratagene) using 44 Ci of 32 P-UTP. One microgram of 4.2-kb Mc2.17 sequence (19) in pBS SKϩ vector restricted with XhoI served as template. Fmr1 message (500 ng, ϳ4.7 ϫ 10 6 counts) was mixed with protein in 30-l reactions in 1ϫ ERBB binding buffer. The mix was incubated at 30°C for 30 min and uv cross-linked on ice 11 times for 30 s (120 mJ) each (24) . RNase A (Sigma) was added, and the mix was incubated at 37°C for 10 min. SDS sample buffer was added, and the sample was boiled for 3-5 min and then loaded on 7.5% SDS-PAGE minigels (Bio-Rad). Gels were silver-stained, and autoradiography was performed overnight.
Filter Binding Assays-Recombinant Fmrp and 32 P-labeled fulllength fmr1 message as described above were mixed in 50-l reaction volumes of 1ϫ ERBB buffer for 30 min at 30°C. Nitrocellulose filters (Millipore, HAWP 025 00) were pretreated with 0.4 M potassium hydroxide for 40 min, 0.1 M Tris-HCl, pH 7.0 -7.9, for 30 min, and binding buffer for 5 min prior to use. The reaction mix was filtered (ϳ10 s), and the filters were washed with 2.5 ml of IPP150 (150 mM NaCl, 10 mM Tris-HCl, pH 8.0, 0.1% Nonidet P-40, 0.1% NaN 3 ) (25) . Specific activity for the fmr1 probe was 1.5 ϫ 10 4 counts/fmol (see Fig. 5A ) and 7.28 ϫ 10 3 counts/fmol (see Fig. 5C ). Filters were dried, and the nucleic acids retained on the filter were dried and quantitated via scintillation counting (Beckman).
Fmr1 and Human Brain Transcript Binding Assays-Fmr1 cDNA (Mc2.17 cloned into pBS KSϩ) 18 message containing all 17 exons was linearized with either XhoI (ϩ3Ј-UTR) or NsiI (Ϫ3Ј-UTR) and then transcribed, as described above, and biotinylated in vitro (6) . For human brain transcript assays, plasmid DNA from each randomly chosen clone in a pCMV-SPORT TM human brain cDNA library (Life Technologies, Inc.) was linearized by NotI restriction, transcribed, and biotinylated in vitro using Sp6 polymerase (Stratagene). Each message (80 ng) was mixed with 250 ng of FLAG-Fmrp in 1ϫ ERBB buffer and incubated in a 10-l reaction volume at 30°C for 30 min. The RNA was captured with streptavidin-linked magnetic beads (Dynal) and washed three times for 10 min each with 0.7 ml of IPP150 buffer at room temperature. Protein was eluted by boiling the beads in SDS-sample buffer, and visualized via SDS-PAGE and Western blotting. Alternatively, the messages were mixed with 2 l of TnT R transcription/translation mix (Promega) containing either 35 S-labeled wild type Fmrp or 35 S-labeled isoform 4 Fmrp. Neither of the 35 S-labeled proteins had the FLAG epitope. Reactions were performed as above, and the protein was eluted by boiling the beads in protein sample buffer, separated by 12% SDS-PAGE, visualized via phosphorimage, and quantitated by MacBas, version 2.0, software.
RESULTS
Expression and Purification-The mouse cDNA Mc2.17 encodes the Fmrp with 97% amino acid identity and greater than 98% predicted amino acid similarity to human FMRP (18) . We have inserted an eight-amino acid FLAG peptide epitope tag between the second and third amino acids of Fmrp and cloned the full-length construct into the pVL1393 baculovirus transfer vector. Cotransfecting Sf9 insect cells with pVL1393-FLAGfmr1 and linear BaculoGold DNA yielded recombinant baculovirus expressing FLAG-Fmrp using its natural ATG start codon controlled by the polyhedrin promoter. Cell lysates analyzed by SDS-PAGE gels stained for protein show that cells infected with the recombinant baculovirus produce an extra ϳ85-kDa protein band (Fig. 1, A and C) . Western analysis using the anti-FLAG M2 primary antibody detected the FLAGtagged protein in infected cell lysates only, and showed no cross-reactivity to insect proteins (Fig. 1B) . Western analysis using monoclonal anti-Fmrp primary antibody detects the same protein band, with no cross-reactivity to insect cell proteins, confirming its identity as FLAG-Fmrp (data not shown). Similar to Fmrp-translated in vitro and endogenous full-length FMRP in human lymphoblastoid cells, the recombinant protein migrates with an anomalously high apparent molecular weight, larger than predicted from primary amino acid sequence (26) . After lysing the cells, FLAG-Fmrp was purified by affinity chromatography using anti-FLAG M2 antibody matrix and analyzed by Coomassie Blue-stained SDS-PAGE and Western blotting (Fig. 1, C and B, respectively) . One hundred ml of Sf9 cell suspension culture at 1 ϫ 10 6 to 3 ϫ 10 6 cells per ml produced approximately 1 mg of purified FLAG-Fmrp protein.
Homopolymer Binding-We next asked whether the purified recombinant Fmrp displayed the biochemical properties previously observed for Fmrp that had been translated and assayed within wheat germ extract or rabbit reticulocyte lysate (5, 15).
The importance of this question may not be intuitive; our first assumption was that if the protein had not become denatured during purification, then it would behave identically to the unpurified in vitro-translated Fmrp. However, upon careful examination of previous work and considering that Fmrp is one component of multiprotein mRNPs or translation machinery, we could not be certain that Fmrp was the component of the translation lysate that directly bound the mRNA (11) (12) (13) (14) . We performed RNA binding assays with the purified protein, using homopolymer RNAs conjugated to Sepharose beads (21) . The purified FLAG-Fmrp preferentially bound poly(G) much stronger than poly(U) and barely bound poly(C) or poly(A). This specificity is identical to that previously observed with in vitrotranslated Fmrp (5) (Fig. 2A) .
To further assess the binding specificity, we performed competition assays with ribonucleotide homopolymers. Because preliminary evidence showed that Fmrp to has a slow on-rate, requiring at least 10 min for complete binding (data not shown), we premixed Fmrp with free competitor poly(G) or poly(U) for 15 min and then added poly(G)-beads to the binding reaction and incubated 20 -25 min. The G-beads were washed, and the yield of captured Fmrp was analyzed (Fig. 2B) . Poly(G) competed effectively with agarose-conjugated poly(G); an equivalent molar amount of competitor poly(G) reduced the amount of Fmrp captured by at least 50%, whereas a 50-fold molar excess of free poly(G) completely eliminated agaroseconjugated poly(G) from binding to Fmrp. As expected from the poor binding of agarose-conjugated poly(U) to Fmrp, free poly(U) was ineffective in competing with agarose-conjugated poly(G) for Fmrp binding. Conjugation by either a primary amine linkage or an aromatic amine linkage, as described under "Experimental Procedures," did not change these results (data not shown).
To further characterize the interaction of Fmrp with poly(G), a battery of binding conditions were assayed (Fig. 3) . The purified Fmrp bound poly(G) homopolymer beads with a salt sensitivity identical to that reported for Fmrp translated in cell lysates in that binding is abrogated when the binding buffer contains 500 mM NaCl (5). Purified Fmrp retained its binding capacity at 30 and 4°C and in the presence of up to 500 mg per ml of yeast tRNA as competitor. Heparin effectively inhibits Fmrp-poly(G) interaction when present during binding but has no effect when present during the washes (see under "Experimental Procedures"). Heparin has commonly been used during initial stages of DNA-binding and RNA-binding protein purification and competes with DNA for RNA polymerase II in transcription assays in vitro (27) (28) (29) . Recombinant Fmrp also bound poly(G) in 1 ϫ ERBB buffer, which was used to characterize in vitro-translated Fmrp binding to human brain messages (6) .
uv Cross-linking-Earlier studies with in vitro-translated Fmrp indicated that it associates with its own message (6). To demonstrate direct binding of Fmrp to its own message, we performed a uv cross-linking assay. As shown by autoradiograph in Fig. 4A , radiolabeled full-length 4.2-kilobase fmr1 message was mixed in a binding reaction with purified recombinant Fmrp. The reaction was then cross-linked by uv irradiation, treated with RNase, and separated by 7.5% SDS-polyacrylamide gel electrophoresis. The gel was silver-stained to visualize Fmrp, and then autoradiography was used to detect message cross-linked to protein. One microgram of bovine serum albumin failed to cross-link to any fmr1 message (Fig. 4A,  lane 3) , whereas with increasing amounts of Fmrp, there was a concomitant increase in the amount of message cross-linked to the protein (Fig. 4A, lanes 4 -8) . With increasing Fmrp concentrations, a higher molecular weight band became apparent; at 4.8 g of Fmrp, it became the predominant labeled band (Fig.  4A, lane 8) . Both species were recognized by either anti-Fmrp or anti-FLAG antibodies (data not shown). The basis for the appearance of the higher molecular weight species is unclear at the present time.
To further demarcate the portion of the fmr1 message interacting with Fmrp, transcripts driven off a template cleaved with either XhoI or NsiI were evaluated in a biotinylated RNA capture assay (see under "Experimental Procedures"). binding assay and analyzed on 7.5% polyacrylamide gels allows separation of the two FLAG-tagged species as detected by Western analysis using the anti-FLAG primary antibody (data not shown).
mRNA Binding-Filter binding assays were performed as an additional method to assess RNA binding.
32 P-labeled fmr1 message alone exhibited a low binding capacity when up to 1 nM quantities were passed through 0.45 m nitrocellulose filters. However, when premixed with 5.7 nM purified Fmrp, the binding of the labeled fmr1 message increased with increasing RNA levels, as judged by captured radioactivity (Fig. 5A) . Saturation appeared evident at approximately 500 pM message. When the binding assay was repeated with 57 nM Fmrp, a 10-fold increase in bound radioactivity was observed at all RNA concentrations tested.
We next tested the ability of a naturally occurring isoform of Fmrp to bind RNA in this assay. Isoform 4 is a variant Fmrp produced by alternative splicing that results in the deletion of exon 14 (18) . This deletion causes a reading frameshift between exons 13 and 15, thereby creating a novel carboxyl terminus. Isoform 4 lacks the RGG-box motifs and the nuclear export signal (7) . The in vitro transcription/translation product of isoform 4 was first tested for its ability to bind fmr1 message according to the previously published method of biotinylated-RNA capture of radiolabeled protein. As shown in Fig. 5B and consistent with our previous observation (6) , approximately 40% of the full-length Fmrp, translated from plasmid 2.17 transcript, was captured by biotinylated fmr1 message. In contrast, despite an 8-fold increase in isoform 4 Fmrp, less than 0.5% of the input isoform 4 was captured by this assay. Accordingly, hexahistidine-tagged isoform 4 protein, prepared and isolated as described under "Experimental Procedures," did not bind fmr1 RNA when tested in the filter binding assay. As shown in Fig. 5C , very little fmr1 message was captured over the range of concentrations tested. These data demonstrate that this naturally occurring isoform fails to bind RNA in vitro, thereby implying a functional distinction between isoforms of Fmrp.
The biotinylated fmr1 message capture assay was next modified using purified Fmrp instead of radiolabeled in vitro-translated Fmrp, and bound protein was detected by Western analysis. In this assay, as in the previous assays, purified recombinant Fmrp bound to its own message. This binding was dramatically reduced if the message was truncated in the 3Ј-UTR (Fig. 6) . In order to determine whether the purified Fmrp selectively binds complex mRNAs, we tested four cloned human brain cDNAs. The transcribed RNAs most likely to contained the 3Ј-ends of brain messages, due to the construction of the cDNA library (pCMV-SPORT human brain library, Life Technologies, Inc.). As shown in Fig. 6 , two of the clones tested produced biotinylated transcript that fail to capture purified Fmrp (lanes 1 and 4) , whereas the other two cDNAs produced transcripts that exhibited modest and rather marked affinity to Fmrp (lanes 2 and 3, respectively) . These results were consistent with those observed with the in vitro-translated protein; ability to capture Fmrp was not related to the size of the transcripts assayed. These experiments were performed with equivalent molar amounts of each transcript in the presence of 100-fold excess of yeast tRNA as a nonspecific RNA competitor. The cDNAs were partially sequenced, and a Basic Local Alignment Search Tool data base search identified cDNAs 2 and 3 as the 3Ј-UTR of myelin basic protein and human EST KIAA0017, respectively.
I304N Fmrp-The FLAG-tagged version of Fmrp was modified to produce the I304N missense mutation of severe fragile X syndrome (19) . It previously been suggested that this amino acid change results in the unfolding of the second KH domain and may abrogate RNA binding (30) . (18), lacks exon 14 and RGG sequences, has a novel carboxyl terminus, and is deficient in nuclear export (7) . Here, 35 Slabeled Fmrp isoform 4 was assayed for fmr1 RNA binding in the biotinylated transcript binding assay (see under "Experimental Procedures"). T, input translation material; B, material bound by fmr1 message. C, comparing the binding of recombinant wild type Fmrp (60 nM) to recombinant His 6 isoform 4 Fmrp (60 nM) by filter binding assay.
FIG. 6. Recombinant Fmrp binds to human brain messages.
FLAG-Fmrp binds differentially to human brain RNAs. Fmrp was mixed in a binding reaction with biotinylated RNAs transcribed in vitro from randomly chosen human brain cDNA clones 1-4. ϩ3ЈUTR, the fmr1 message with its 3ЈUTR; Ϫ3ЈUTR, the fmr1 message lacking a 3ЈUTR. Protein bound to captured messages was eluted and analyzed by 12% SDS-PAGE and Western blotting. recombinant I304N Fmrp was purified as described above for wild type Fmrp and subjected to homopolymer binding. As shown in Fig. 7, I304N protein clearly bound selectively to poly(G), although with slightly reduced yield as compared with wild type; this is seen more clearly in the poly(U) experiments. DISCUSSION We have used the baculovirus system to express high levels of FLAG-Fmrp and purify the protein to apparent homogeneity under relatively nondenaturing conditions. The purified FLAGFmrp protein appears biochemically intact and active. It displays the same homopolymer association properties as in vitrotranslated Fmrp, binding poly(G) Ͼ poly(U) Ͼ Ͼ poly(C) and poly(A). The RNA binding activity is therefore an intrinsic property of the Fmrp molecule, independent of Fmrp interaction with other proteins. This point is of some significance. Because previous studies did not utilize purified preparations, it had remained unclear whether or not the selectivity and, indeed, RNA binding were functional attributes of Fmrp alone or required association with other proteins. The selective RNA binding demonstrated by the purified protein will now allow the capture and characterization of cognate RNA species by epitope-immobilized purified Fmrp.
We have also demonstrated that FLAG-Fmrp directly binds to the 3Ј-untranslated portion of its own transcript. Moreover, of the two RNAs found in this study to bind Fmrp well, one was the 3Ј-UTR of myelin basic protein. Although it is difficult at the present time to discern any similarity between these RNA sequences that may direct binding, the observation of 3Ј-UTR interaction is interesting. The 3Ј-UTRs of mRNA have been found to often be targets for RNA-binding proteins, the interactions of which may regulate translational efficiency and or mRNA stability (31) (32) (33) (34) (35) . Although it is premature to interpret the Fmrp binding to the 3Ј-UTRs of both its own message and that of myelin basic protein, one might speculate a functional significance. Additional studies, such as adding either 3Ј-UTR to a reporter construct and transfecting into normal and Fmrpdeficient cells, are needed.
It was also demonstrated, utilizing both in vitro-translated and purified protein, that a naturally occurring isoform of Fmrp, isoform 4, is severely impaired in RNA binding. This isoform is devoid of exon 14-coded residues and, because of a frameshift at the alternative splice, has a distinct carboxyl terminus (18) . The loss of exon 14 results in the absence of the nuclear export signal from Fmrp, leading to nuclear localization (7), whereas the alternative carboxyl terminus no longer contains the RGG box (18, 36) . Because isolated KH domains have been considered sufficient to direct RNA binding (37) , it is unexpected that isoform 4 interacts only weakly with RNA. It is possible that either the RGG box directs RNA binding or any or all of the absent sequences alter the conformation of the KH domains, limiting their ability to interact with RNA. Whatever the mechanism, these data imply that isoform 4 does not bind RNA as well as the wild type does. It is also confined to the nucleus, thereby having significantly distinct attributes from the full-length Fmrp. Because it is possible that isoform 4 may still interact with at least some of the nuclear proteins that normally constitute the mRNP along with full-length Fmrp (13), isoform 4 may act to sequester these proteins, perhaps limiting the formation of the normal Fmrp mRNP. Although it is possible that the purification and refolding of isoform 4 may have produced a nonnative conformation in the protein, parallel studies with in vitro-translated isoform 4 support the observed impaired RNA binding of this isoform.
In contrast to the diminished RNA binding of isoform 4, we demonstrate that protein bearing the I304N mutation in the second KH domain of Fmrp retains a significant amount of RNA binding ability. This is in contrast to earlier studies that speculated that, based upon NMR-derived structure of an isolated KH domain, the I304N mutation should abolish RNA binding due to complete unfolding of the KH structure (30) . Our observation of RNA binding by the purified I304N protein (albeit slightly less than the wild type protein, but with selectivity similar to that of the wild type protein) suggests that the I304N mutation is not destabilizing when incorporated within the full-length protein. The unfolding of the isolated KH domain, apparently caused by this mutation, was supported by work of Siomi et al. (5, 15) , which showed that in vitro-translated I304N Fmrp lost poly(U) binding in 250 mM NaCl, whereas wild type protein did not. We also demonstrate that purified I304N protein has a greater salt sensitivity than wild type protein in regard to poly(U) binding (in 100 mM NaCl, the I304N protein was unable to bind poly(U) but retained poly(G) binding). Our observation of a more severe salt sensitivity with the purified mutant protein than the in vitro-translated protein (which could bind poly(U) at 100 mM NaCl (15)) may suggest that interacting proteins within the reticulocyte lysate may partially stabilize the I304N Fmrp. Indeed, this possibility is supported by our recent observation that the human cellular I304N FMRP retains RNA binding in vivo but forms a mRNP of altered mass and density, suggesting that the mutation influences protein-protein interaction more than RNA-protein interaction at physiological salt concentrations (13).
As described above, recombinant epitope-tagged forms of Fmrp can be prepared in mg quantities at near homogeneous levels of purity. The observations that wild type purified Fmrp has autonomous and selective RNA binding, whereas the I304N mutation in the second KH domain exhibits selective RNA binding with a greater salt sensitivity, demonstrate that the functional attributes of the protein were maintained throughout the purification process. The significant reduction in RNA binding by isoform 4 suggests distinctive functional attributes for this alternatively spliced form of Fmrp. Based on the above characterization of the purified proteins, structural studies of Fmrp are now possible, the results of which should shed considerable insight specifically into Fmrp and, more broadly, into KH domain proteins in general. FIG. 7 . Purified recombinant I304N Fmrp binds preferentially to poly(G) homopolymer. Standard binding reactions in 1ϫ binding buffer with 100 mM NaCl were performed using purified recombinant wild type Fmrp (G and U) or with purified recombinant Fmrp carrying the point mutation found in severe fragile X sydrome (G, U, A, C, and Ϫ). Input lanes: 250 ng of purified protein loaded directly onto gel represents 1 ⁄2 of the input protein in each reaction; Ϫ indicates naked beads (no RNA). Approximately 55% of the reaction yield was visualized by SDS-PAGE and immunoblotting (see under "Experimental Procedures").
